Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-28 02:30:19 - browse：82

Neurocrine Biosciences decided to join PhRMA. Adobe

WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Study fuels hope CAR

WSS

Laying a path for careers in science

Erich Jarvis studies song birds to learn about human stuttering

'Patient friction coefficient' can gauge a clinical trial's patient burden

Ohio train derailment: Experts on toxic chemical risks

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Pfizer is about to make a big push in cancer. Will investors listen?

explore

Wikipedia

focus

Drug repurposing or repositioning? The language matters

Are embryos people? Reproductive medicine's future depends on the answer

Jerome Adams on the need for new antivirals for Covid

Steward Health Care expansion into Malta flopped

Virginia high school admissions case could be legal follow

What Kate Middleton's cancer revelation might teach the world

Duchenne breakthrough therapy leaves behind pioneering families

Ohio train derailment: Experts on toxic chemical risks

New air purifier tech could be key to improving indoor air quality

Cancer, immunology, HIV research ensnared in fetal tissue politics

entertainment

Study fuels hope CAR

Cancer, immunology, HIV research ensnared in fetal tissue politics

This gene therapy has record $4.25 million price. It's saved children.

Pfizer is about to make a big push in cancer. Will investors listen?

Mirador, a new biotech startup, launches with $400 million

'Vaccine

hotspot

explore

leisure time

focus